Inicio › Esteatosis hepática › Ohio
Ensayos clínicos de Esteatosis hepática en Ohio
15 estudios sobre Esteatosis hepática buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Springboro
- GSK Investigational Site, Westlake
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07704892Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Cleveland Clinic, Cleveland
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 28 sept 2026 · NCT05832229A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Akron Gastro Research, Akron
- Dayton Gastroenterology - Beavercreek, Beavercreek
- Clinical Research Institute of Ohio - Brooklyn, Brooklyn
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07165028Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 2
Edades de 5 a 16 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06133101A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Akron
- Akero Clinical Study Site, Springboro
- Akero Clinical Study Site, Westlake
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Akron
- GSK Investigational Site, Springboro
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Akron Gastro Research, Akron
- Digestive Specialists, Dayton
- DSI Research, Springboro
- y 1 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07288138A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Akron
- 89bio Clinical Study Site, Cincinnati
- 89bio Clinical Study Site, Cleveland
- y 5 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Akron
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Dayton
- y 4 más
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06318169A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Cleveland
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06613698Fibrosis Lessens After Metabolic Surgery
- Cleveland Clinic, Cleveland
ReclutandoFase 4Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 31 jul 2026 · NCT06374875A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Akron
- GSK Investigational Site, Springboro
- GSK Investigational Site, Westlake
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07221227Milk Thistle Clinical Trial in Pediatric NAFLD
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 2
Edades de 9 a 22 · Todos los sexos · Actualizado el 27 ene 2026 · NCT06477146Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
- southwoods imaging (Northeastern Ohio Radiology Research and Education Fund ), Boardman
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2025 · NCT07192159Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- Ohio Clinical Trials, Columbus
ReclutandoEstudio observacional
Edades de 18 a 75 · Todos los sexos · Actualizado el 14 ago 2025 · NCT07122700De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.